Search research articles
Contact Us
Filters
Showing results (51-60 of 95) with videos related to
Page
of 10
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics
|
March 22, 2006
Optimal design for multivariate response pharmacokinetic models
Ivelina Gueorguieva, Leon Aarons, Kayode Ogungbenro, et al.
Clinical Pharmacology and Therapeutics
|
June 2, 2022
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease
Hiroyuki Takita, Daniel Scotcher, Xiaoyan Chu, et al.
Cancer Chemotherapy and Pharmacology
|
March 15, 2020
Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation
Aurélie Lombard, Hitesh Mistry, Sonya C Chapman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 14, 2018
Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin I
Shelby Barnett, Kayode Ogungbenro, Karelle Ménochet, et al.
European Journal of Clinical Pharmacology
|
June 8, 2019
A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents
Kayode Ogungbenro, Jonathan B Wagner, Susan Abdel-Rahman, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 5, 2021
Investigating the impact of target lesion selection on drug effect evaluation and tumour growth rate determination using tumour growth inhibition models: Example of malignant pleural mesothelioma patients treated with cisplatin alone or in combination with pemetrexed
Aurélie Lombard, Hitesh Mistry, Sonya C Chapman, et al.
Molecular Pharmaceutics
|
June 17, 2025
Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future Trajectories
Saeed Rezaee, Zubida M Al-Majdoub, Aleksandra Galetin, et al.
Journal of Clinical Pharmacology
|
September 5, 2020
Does "Birth" as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full-Term Neonates by Avoiding the Creatinine Bias
Farzaneh Salem, Trevor N Johnson, Arran B J Hodgkinson, et al.
Analytical Methods : Advancing Methods and Applications
|
March 21, 2023
Development of a sensitive biochemical assay for the detection of tofacitinib adherence
Stephanie Church, Kimme L Hyrich, Kayode Ogungbenro, et al.
Clinical and Translational Science
|
November 11, 2025
Translatability of Animal Models for Alzheimer's Disease Using a Machine Learning Based Workflow
Alex Foster-Powell, Guy Meno-Tetang, Amin Rostami-Hodjegan, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 95) with videos related to
Sort By:
Page
of 10
Journal of Pharmacokinetics and Pharmacodynamics
|
March 22, 2006
Optimal design for multivariate response pharmacokinetic models
Ivelina Gueorguieva, Leon Aarons, Kayode Ogungbenro, et al.
Clinical Pharmacology and Therapeutics
|
June 2, 2022
Coproporphyrin I as an Endogenous Biomarker to Detect Reduced OATP1B Activity and Shift in Elimination Route in Chronic Kidney Disease
Hiroyuki Takita, Daniel Scotcher, Xiaoyan Chu, et al.
Cancer Chemotherapy and Pharmacology
|
March 15, 2020
Impact of tumour size measurement inter-operator variability on model-based drug effect evaluation
Aurélie Lombard, Hitesh Mistry, Sonya C Chapman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 14, 2018
Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin I
Shelby Barnett, Kayode Ogungbenro, Karelle Ménochet, et al.
European Journal of Clinical Pharmacology
|
June 8, 2019
A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents
Kayode Ogungbenro, Jonathan B Wagner, Susan Abdel-Rahman, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 5, 2021
Investigating the impact of target lesion selection on drug effect evaluation and tumour growth rate determination using tumour growth inhibition models: Example of malignant pleural mesothelioma patients treated with cisplatin alone or in combination with pemetrexed
Aurélie Lombard, Hitesh Mistry, Sonya C Chapman, et al.
Molecular Pharmaceutics
|
June 17, 2025
Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future Trajectories
Saeed Rezaee, Zubida M Al-Majdoub, Aleksandra Galetin, et al.
Journal of Clinical Pharmacology
|
September 5, 2020
Does "Birth" as an Event Impact Maturation Trajectory of Renal Clearance via Glomerular Filtration? Reexamining Data in Preterm and Full-Term Neonates by Avoiding the Creatinine Bias
Farzaneh Salem, Trevor N Johnson, Arran B J Hodgkinson, et al.
Analytical Methods : Advancing Methods and Applications
|
March 21, 2023
Development of a sensitive biochemical assay for the detection of tofacitinib adherence
Stephanie Church, Kimme L Hyrich, Kayode Ogungbenro, et al.
Clinical and Translational Science
|
November 11, 2025
Translatability of Animal Models for Alzheimer's Disease Using a Machine Learning Based Workflow
Alex Foster-Powell, Guy Meno-Tetang, Amin Rostami-Hodjegan, et al.
Page
of 10